Use our new account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
CLI Leadership & Staff

David Prentice, Ph.D.

Vice President of Scientific Affairs

David A. Prentice is Vice President of Scientific Affairs for the Charlotte Lozier Institute.  He is also Advisory Board Chair and a Founding Member for the Midwest Stem Cell Therapy Center, a unique comprehensive stem cell center in Kansas that he was instrumental in creating.  In 2020, he was appointed by the Secretary of HHS to the federal Human Fetal Tissue Ethics Advisory Board.  Dr. Prentice has almost 50 years’ experience as a scientific researcher and professor, including previous service as senior fellow for life sciences at the Family Research Council, Professor of Life Sciences at Indiana State University, Adjunct Professor of Medical and Molecular Genetics, Indiana University School of Medicine, and Adjunct Professor of Molecular Genetics at the John Paul II Institute, Catholic University of America.

He established Stem Cell Research Facts, an educational website providing scientific facts and patient-centered videos about adult stem cells, and is a founding member of Do No Harm: The Coalition of Americans for Research Ethics, and an advisory board member for the Center for Bioethics and Human Dignity.  He has provided scientific advice for numerous medical and science professionals, legislators, policymakers and organizations at the state, federal, and international levels.

Dr. Prentice received his Ph.D. in biochemistry from the University of Kansas, and was at Los Alamos National Laboratory and the University of Texas Medical School-Houston before joining Indiana State University where in addition to his research and teaching, he served as Acting Associate Dean of Arts and Sciences and Assistant Chair of Life Sciences. He was recognized with the University’s Caleb Mills Distinguished Teaching Award and Faculty Distinguished Service Award.  He has taught subjects ranging from non-majors biology to advanced and graduate courses including developmental biology, embryology, cell and tissue culture, history of biology, science and politics, pathophysiology, medical genetics, and medical biochemistry. Several of his courses were also taught on-line.

He received the 2007 Walter C. Randall Award in Biomedical Ethics from the American Physiological Society, given for promoting the honor and integrity of biomedical science through example and mentoring in the classroom and laboratory.  He was honored in 2018 with selection for the 31st A. Kurt Weiss Lectureship on Biomedical Ethics, Oklahoma University Health Science Center. Dr. Prentice’s research interests encompass various aspects of cell growth control, cell and developmental biology; one major focus is adult stem cells.  He has reviewed for various professional publications including The Journal of the American Medical Association.

He is an internationally-recognized expert on stem cell research, cell biology and bioethics, and has provided scientific lectures and policy briefings in 40 states and 21 countries, including testimony before the U.S. Congress and numerous state legislatures, the U.S. National Academy of Sciences, the U.S. President’s Council on Bioethics, European Parliament, British Parliament, Canadian Parliament, Australian Parliament, German Bundestag, French Senate, Swedish Parliament, the United Nations, and the Vatican.  He was selected by President George W. Bush’s U.S. President’s Council on Bioethics to write the comprehensive review of adult stem cell research for the Council’s 2004 publication “Monitoring Stem Cell Research.”

Dr. Prentice has published numerous scientific and bioethics articles, including a review of stem cell science and adult stem cell treatments published in Circulation Research.  He has also published numerous commentaries and op-eds, and travels nationally and internationally to give invited lectures regarding stem cell research, fetal tissue research, gene editing, cloning, embryology, cell and developmental biology, cell culture and vaccines, bioethics, and public policy.  He has been interviewed in virtually all major electronic and print media outlets, including CNN, ABC, NBC, CBS, Fox, CSPAN, Reuters, AP, NPR, USA Today, BBC, The Washington Post, The Los Angeles Times, and The New York Times.

Research Authored

featured-image
Press Release

Major Pro-life Victory: HHS Cancels Huge Contract for Taxpayer-Funded Experimentation with Body Parts of Aborted Babies, Announces New Approach

Today’s move demonstrates NIH’s investment in scientifically-proven methods for research: adult stem cells, iPS cells, organoids, humanized mice constructed using postnatally sourced cells and improved non-human cell lines—just to name a few.

featured-image
Peer Reviewed

Adult Stem Cells: Successful Standard for Regenerative Medicine

Adult stem cells are the successful standard for stem cells. Although in the past their regenerative/reparative capacity was ignored, misunderstood, or even maligned, a rapidly growing host of clinical applications are being developed, and the clinical utility of adult stem cells is increasingly validated in the literature.

featured-image
Abortion

Written Testimony of David A. Prentice, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” 

featured-image
Stem Cells & Therapies

Dr. David Prentice: U.S. Gov’t Must Stop Using Aborted Baby Parts for Research

Dr. Prentice explains the ethical alternatives and the need for the government to lead the way in cutting-edge science.

featured-image
Fetal Tissue, Stem Cells & Bioethics

Adult Stem Cells and Gene Therapy Save a Young Boy

When people talk about something that “saved their skin,” they usually mean that it helped them out of a difficult situation. But a young boy in Germany has literally had his skin—and his life—saved through the use of genetically-engineered adult stem cells.

featured-image
Stem Cells & Therapies

Dr. David Prentice on Embracing Ethical New Technologies

Some scientists have said one reason they don’t consult bioethicists or think about the ethical implications of their research is because ethicists usually say “no” to new technologies, or that ethics is arbitrary. But what they are really avoiding is the necessity

Stem Cells & Therapies

Dr. David Prentice: “What’s All the Fuss About Stem Cells?”

What are stem cells and why are they so fraught with both hope and controversy? CLI’s Vice President and Research Director, Dr. David Prentice, recently joined Molly Smith, host of From the Median, to explain the science, history, and politics of stem cells

featured-image
Fetal Tissue, Stem Cells & Bioethics

Seeking Pro-life Leadership at the National Institutes of Health

In a recent op-ed, Dr. David Prentice and Congressman Jim Banks argue that it’s time for a change in leadership at the National Institutes of Health: Dr. Francis Collins has not shown any pro-life leadership at the National Institutes of Health (NIH). In

featured-image
Peer Reviewed

Improving Maternal Mortality: Comprehensive Reporting for All Pregnancy Outcomes

To demonstrate the impact of inadequate standardization and population coverage on the ability to measure and improve maternal mortality in the United States.

featured-image
Stem Cells & Therapies

Backgrounder: We Need a New NIH Director

On April 25, 2017, Charlotte Lozier Institute Vice President and Director of Research, Dr. David A. Prentice, Ph.D., was published in USA Today on the need for a new National Institutes of Health (NIH) Director. The backgrounder below provides summary main points